A Phase I-II Randomized Trial of a Combination of Nintedanib/Placebo in Combination With Induction Chemotherapy for Patients With Refractory or First Relapse Acute Myeloid Leukemia
Phase of Trial: Phase I/II
Latest Information Update: 02 Apr 2018
At a glance
- Drugs Cytarabine (Primary) ; Idarubicin (Primary) ; Nintedanib (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 20 Jun 2016 Status changed from not yet recruiting to recruiting.
- 13 May 2016 Planned initiation date changed from 1 Feb 2016 to 1 May 2016.
- 12 Feb 2016 New trial record